Staphylococcus aureus antigens and challenges in vaccine development.
about
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposurePushing the frontiers of T-cell vaccines: accurate measurement of human T-cell responses.Proteomics-based identification of anchorless cell wall proteins as vaccine candidates against Staphylococcus aureusDesign of live attenuated bacterial vaccines based on D-glutamate auxotrophy.Progress in the development of effective vaccines to prevent selected gram-positive bacterial infections.Evaluation of clumping factor A binding region A in a subunit vaccine against Staphylococcus aureus-induced mastitis in mice.Safety and immunogenicity of a novel Staphylococcus aureus vaccine: results from the first study of the vaccine dose range in humansAnti-Staphylococcus aureus single-chain variable region fragments provide protection against mastitis in mice.Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.Intramammary Immunization of Pregnant Mice with Staphylococcal Protein A Reduces the Post-Challenge Mammary Gland Bacterial Load but Not Pathology.Meta-Analysis of Transcriptional Responses to Mastitis-Causing Escherichia coliInnate and Adaptive Immunity Synergize to Trigger Inflammation in the Mammary Gland.Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis modelCharacterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections.Evaluation of humoral immunity and protective efficacy of biofilm producing Staphylococcus aureus bacterin-toxoid prepared from a bovine mastitis isolate in rabbit.The T Cell Response to Staphylococcus aureusTargeting mucosal immunity in the battle to develop a mastitis vaccine.Challenges for a universal Staphylococcus aureus vaccine.Immunoprophylaxis and immunotherapy of Staphylococcus epidermidis infections: challenges and prospects.Comparative studies of the immunogenicity and protective potential of biofilm vs planktonic Staphylococcus aureus vaccine against bovine mastitis using non-invasive mouse mastitis as a model system.Typing of Staphylococcus aureus isolated from bovine mastitis cases in Australia and India.Diversity of Virulence Factors Associated with West Australian Methicillin-Sensitive Staphylococcus aureus Isolates of Human Origin.Selection and characterization of murine monoclonal antibodies to Staphylococcus aureus iron-regulated surface determinant B with functional activity in vitro and in vivo.Immune response of heifers against a Staphylococcus aureus CP5 whole cell vaccine formulated with ISCOMATRIX™ adjuvant.The role of vaccines in preventing bacterial antimicrobial resistance.Hierarchy of human IgG recognition within the Staphylococcus aureus immunome
P2860
Q28714292-BDCD4A75-1F14-4006-8D06-C2676FA88605Q30416916-9C68A158-B5B7-4906-972D-000410E291F0Q33429774-953AAF3B-6B98-4481-A959-130FBF0B5FD8Q33763029-0DF7217C-F895-4170-84A4-9AABB1968BB4Q34112608-3D7824B8-8F6E-4B77-BD30-890119211CA5Q34289853-3D9E2F74-C0A1-4F69-A923-7539AB4945E7Q34431997-591DECEE-0B3A-42C5-8DCE-C77C26167C6BQ35825443-0CC776F0-8628-450D-8D87-B023D83FD96FQ35827070-D803B7A3-1A2A-4C1A-9496-A559C3450434Q35919380-CC2CC7CB-562C-45E6-B1BE-2B876D4F5950Q35942639-3BF80FE6-050C-412C-8068-F1A2E1076C35Q35995827-AE566CF8-1CE9-47F4-B4A4-6F6B88E83BAFQ36184397-66BC05BC-93D2-4CB6-8AE8-3AD9FA9FD6DCQ36195087-7DEED03C-7475-4C44-98E7-550BF85AD355Q36680357-D682F92E-1D2C-43BC-A7F2-AC50EDB6B21BQ36735452-7C19865D-DAF2-44C5-8C7D-7B951EDDD84EQ37941987-3C6C710E-FF66-4399-BF97-DB062B83DEEAQ37987099-CE753465-C7F2-4A2D-A939-4D807C8CF781Q37989572-B804115B-EFB0-4BC8-AB74-3DF34E026AB7Q41040837-9CEF5CB3-56E6-4D33-9A3C-275115AECAF2Q41085273-103CDD73-E92F-485B-BD47-DDCA5018F596Q42770328-EB564983-124A-4035-A175-6ADB042C65F5Q43071917-28CC7452-CEBB-4B88-A573-52E3BCF01553Q45829321-2F74C32B-788F-48FB-8A6B-4683E285EE43Q50120750-B5E5D383-5C43-4DB6-8FCA-9706FBF407F6Q58763401-CE6A9EF8-0C8C-493B-BFC6-0161B901D5D8
P2860
Staphylococcus aureus antigens and challenges in vaccine development.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Staphylococcus aureus antigens and challenges in vaccine development.
@en
Staphylococcus aureus antigens and challenges in vaccine development.
@nl
type
label
Staphylococcus aureus antigens and challenges in vaccine development.
@en
Staphylococcus aureus antigens and challenges in vaccine development.
@nl
prefLabel
Staphylococcus aureus antigens and challenges in vaccine development.
@en
Staphylococcus aureus antigens and challenges in vaccine development.
@nl
P2860
P356
P1476
Staphylococcus aureus antigens and challenges in vaccine development.
@en
P2093
John R Middleton
P2860
P304
P356
10.1586/14760584.7.6.805
P577
2008-08-01T00:00:00Z